Spruce Biosciences annual depreciation and amortization
2019
2020
2021
2022
2023
2024
2025
Spruce Biosciences Depreciation & Amortization Growth & History (SPRB)
Spruce Biosciences's depreciation and amortization was $21,000 for fiscal 2025.
View full Spruce Biosciences company overviewSpruce Biosciences annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $21,000 | −$25,000 | −54.35% |
| 2024 | 2024-12-31 | $46,000 | −$24,000 | −34.29% |
| 2023 | 2023-12-31 | $70,000 | −$4,000 | −5.41% |
| 2022 | 2022-12-31 | $74,000 | $6,000 | +8.82% |
| 2021 | 2021-12-31 | $68,000 | $32,000 | +88.89% |
| 2020 | 2020-12-31 | $36,000 | $24,000 | +200.00% |
| 2019 | 2019-12-31 | $12,000 | — | — |
Spruce Biosciences quarterly depreciation and amortization
Q1.20
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $631,000 | $624,000 | +8914.29% |
| Q1 2026 | 2026-03-31 | $252,000 | $246,000 | +4100.00% |
| Q4 2025 | 2025-12-31 | $5,000 | — | — |
| Q3 2025 | 2025-09-30 | $3,000 | −$7,000 | −70.00% |
| Q2 2025 | 2025-06-30 | $7,000 | −$5,000 | −41.67% |
| Q1 2025 | 2025-03-31 | $6,000 | −$9,000 | −60.00% |
| Q3 2024 | 2024-09-30 | $10,000 | −$7,000 | −41.18% |
| Q2 2024 | 2024-06-30 | $12,000 | −$6,000 | −33.33% |
| Q1 2024 | 2024-03-31 | $15,000 | −$4,000 | −21.05% |
| Q3 2023 | 2023-09-30 | $17,000 | −$6,000 | −26.09% |
| Q2 2023 | 2023-06-30 | $18,000 | $12,000 | +200.00% |
| Q1 2023 | 2023-03-31 | $19,000 | −$2,000 | −9.52% |
| Q3 2022 | 2022-09-30 | $23,000 | $5,000 | +27.78% |
| Q2 2022 | 2022-06-30 | $6,000 | −$11,000 | −64.71% |
| Q1 2022 | 2022-03-31 | $21,000 | $8,000 | +61.54% |
| Q3 2021 | 2021-09-30 | $18,000 | $10,000 | +125.00% |
| Q2 2021 | 2021-06-30 | $17,000 | $0 | 0.00% |
| Q1 2021 | 2021-03-31 | $13,000 | $12,000 | +1200.00% |
| Q3 2020 | 2020-09-30 | $8,000 | — | — |
| Q2 2020 | 2020-06-30 | $17,000 | — | — |
| Q1 2020 | 2020-03-31 | $1,000 | — | — |
Spruce Biosciences depreciation and amortization trends
Over the last five fiscal years, Spruce Biosciences's depreciation and amortization decreased from $36,000 to $21,000, a change of −$15,000. The latest reported quarter, Q2 2026, shows $631,000.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Spruce Biosciences source filings ↗